{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:53:01Z","timestamp":1790916781024,"version":"4.1.0"},"reference-count":191,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T00:00:00Z","timestamp":1786147200000},"content-version":"vor","delay-in-days":219,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.ctarc.2026.101363","type":"journal-article","created":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T05:33:05Z","timestamp":1786771985000},"page":"101363","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Role of non-animal 3D models in H. pylori associated gastric carcinogenesis: Insights and future perspectives"],"prefix":"10.1016","volume":"48","author":[{"given":"Randhir","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dyumn","family":"Dwivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anshu","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Chaturvedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sourabh","family":"Tyagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemant","family":"Ritturaj Kushwaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupesh","family":"Chaturvedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruti","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctarc.2026.101363_bib0001","series-title":"StatPearls [Internet]","article-title":"Gastric cancer","author":"Menon","year":"2025"},{"issue":"10251","key":"10.1016\/j.ctarc.2026.101363_bib0002","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","article-title":"Gastric cancer","volume":"396","author":"Smyth","year":"2020","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101363_bib0003","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/0971-5851.81883","article-title":"Epidemiological review of gastric cancer in India","volume":"32","author":"Dikshit","year":"2011","journal-title":"Indian J. Med. Paediatr. Oncol."},{"key":"10.1016\/j.ctarc.2026.101363_bib0004","doi-asserted-by":"crossref","first-page":"52","DOI":"10.21037\/tgh.2020.01.02","article-title":"Diffuse gastric cancer: histologic, molecular, and genetic basis of disease","volume":"5","author":"Iyer","year":"2020","journal-title":"Transl. Gastroenterol. Hepatol."},{"issue":"18","key":"10.1016\/j.ctarc.2026.101363_bib0005","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.3390\/cancers16183163","article-title":"Gastric cancer: an up-to-date review with new insights into early-onset Gastric cancer","volume":"16","author":"Mazurek","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"11","key":"10.1016\/j.ctarc.2026.101363_bib0007","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.3390\/ijms21114012","article-title":"Gastric cancer: epidemiology, risk factors, classification, genomic characteristics and treatment strategies","volume":"21","author":"Machlowska","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ctarc.2026.101363_bib0008","article-title":"Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention","year":"2025","journal-title":"Nature Rev. Clin. Oncol. [Internet]"},{"key":"10.1016\/j.ctarc.2026.101363_bib0009","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.3389\/fphar.2018.01421","article-title":"CDH1 Gene and hereditary diffuse gastric cancer syndrome: molecular and histological alterations and implications for diagnosis and treatment","volume":"9","author":"Luo","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ctarc.2026.101363_bib0010","article-title":"Gastric cancer\u2014Epidemiology, modifiable and non-modifiable risk factors, challenges and opportunities: an updated review","volume":"41","author":"Mamun","year":"2024","journal-title":"Cancer Treat. Res. Commun."},{"key":"10.1016\/j.ctarc.2026.101363_bib0011","article-title":"Helicobacter pylori co-infection with Epstein-Barr virus and the risk of developing gastric adenocarcinoma at an early age: observational study infectious agents and cancer","volume":"68","author":"Rihane","year":"2021","journal-title":"Ann. Med. Surg. (Lond)"},{"issue":"5","key":"10.1016\/j.ctarc.2026.101363_bib0012","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.3390\/microorganisms11051312","article-title":"Helicobacter pylori and its role in gastric cancer","volume":"11","author":"Reyes","year":"2023","journal-title":"Microorganisms"},{"issue":"2","key":"10.1016\/j.ctarc.2026.101363_bib0013","doi-asserted-by":"crossref","first-page":"147","DOI":"10.4251\/wjgo.v8.i2.147","article-title":"Role of Helicobacter pylori in gastric cancer: updates","volume":"8","author":"Khatoon","year":"2016","journal-title":"World J. Gastrointest. Oncol."},{"key":"10.1016\/j.ctarc.2026.101363_bib0014","series-title":"Helicobacter pylori: Physiology and Genetics [Internet]","article-title":"Gastric cancer","author":"Asaka","year":"2001"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101363_bib0015","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3390\/microorganisms12010222","article-title":"Helicobacter pylori: a contemporary perspective on pathogenesis, diagnosis treatment strategies","volume":"12","author":"Ali","year":"2024","journal-title":"Microorganisms"},{"key":"10.1016\/j.ctarc.2026.101363_bib0016","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13045-024-01654-2","article-title":"Helicobacter pylori and gastric cancer: mechanisms and new perspectives","volume":"18","author":"Duan","year":"2025","journal-title":"J. Hematol. Oncol."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101363_bib0017","first-page":"49","article-title":"Gastric cancer: clinical features, screening, diagnosis, treatment, and prevention","volume":"14","author":"Ramachandran","year":"2024","journal-title":"J. Community Hosp. Intern. Med. Perspect."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101363_bib0018","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41591-024-03489-3","article-title":"Clinical applications of human organoids","volume":"31","author":"Verstegen","year":"2025","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101363_bib0019","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s43586-022-00174-y","article-title":"Organoids","volume":"2","author":"Zhao","year":"2022","journal-title":"Nat. Rev. Methods Primers"},{"issue":"12","key":"10.1016\/j.ctarc.2026.101363_bib0020","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1002\/stem.3379","article-title":"Organoid technology: current standing and future perspectives","volume":"39","author":"Shariati","year":"2021","journal-title":"Stem Cells (1981)"},{"issue":"4","key":"10.1016\/j.ctarc.2026.101363_bib0021","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.cell.2018.07.027","article-title":"Divergent routes toward wnt and responding niche independency during Human gastric carcinogenesis","volume":"174","author":"Nanki","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.ctarc.2026.101363_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.117942","article-title":"Recent progress on the organoids: techniques, advantages and applications","volume":"185","author":"Liu","year":"2025","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101363_bib0023","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41420-025-02580-z","article-title":"Interplay between genes and social environment: from epigenetics to precision medicine","volume":"11","author":"Caporali","year":"2025","journal-title":"Cell Death Discov."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101363_bib0024","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13148-024-01762-3","article-title":"Environmental exposures influence multigenerational epigenetic transmission","volume":"16","author":"Klibaner-Schiff","year":"2024","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.ctarc.2026.101363_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2025.102270","article-title":"Cellular heterogeneity and communication networks in gastric cancer: single-cell analysis reveals \u03b2-hydroxybutyrylation-associated genes and immune infiltration characteristics","volume":"53","author":"Hu","year":"2025","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.ctarc.2026.101363_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2022.101510","article-title":"Key signal transduction pathways and crosstalk in cancer: biological and therapeutic opportunities","volume":"26","author":"Fu","year":"2022","journal-title":"Transl. Oncol."},{"issue":"21","key":"10.1016\/j.ctarc.2026.101363_bib0027","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252111735","article-title":"Molecular mechanism for malignant progression of gastric cancer within the tumor microenvironment","volume":"25","author":"Matsuoka","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ctarc.2026.101363_bib0028","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.2147\/JIR.S353489","article-title":"Role of JAK2\/STAT3 signaling pathway in the tumorigenesis, chemotherapy resistance, and treatment of solid tumors: a systemic review","volume":"Volume 15","author":"MA","year":"2022","journal-title":"J. Inflamm. Res."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101363_bib0029","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s11033-025-10372-y","article-title":"Molecular mechanisms of Hippo pathway in tumorigenesis: therapeutic implications","volume":"52","author":"Saadh","year":"2025","journal-title":"Mol. Biol. Rep."},{"issue":"11","key":"10.1016\/j.ctarc.2026.101363_bib0030","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/s41573-025-01234-0","article-title":"Targeting the Hippo pathway in cancer","volume":"24","author":"Harvey","year":"2025","journal-title":"Nat. Rev. Drug Discov."},{"issue":"9","key":"10.1016\/j.ctarc.2026.101363_bib0031","article-title":"Targeting the Hippo\/YAP pathway: a promising approach for cancer therapy and beyond","volume":"6","author":"Bala","year":"2025","journal-title":"MedComm. (2020)"},{"issue":"5","key":"10.1016\/j.ctarc.2026.101363_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2024.189139","article-title":"Helicobacter pylori triggers inflammation and oncogenic transformation by perturbing the immune microenvironment","volume":"1879","author":"Wang","year":"2024","journal-title":"Biochimica et Biophysica Acta (BBA) - Rev. Cancer"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101363_bib0033","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41392-021-00762-6","article-title":"Wnt\/\u03b2-catenin signalling: function, biological mechanisms, and therapeutic opportunities","volume":"7","author":"Liu","year":"2022","journal-title":"Sig. Transduct. Target Ther."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101363_bib0034","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13045-024-01563-4","article-title":"Wnt\/\u03b2-catenin signaling pathway in carcinogenesis and cancer therapy","volume":"17","author":"Song","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.ctarc.2026.101363_bib0035","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1410513","article-title":"Wnt signaling in gastric cancer: current progress and future prospects","volume":"14","author":"Han","year":"2024","journal-title":"Front. Oncol."},{"issue":"30","key":"10.1016\/j.ctarc.2026.101363_bib0036","doi-asserted-by":"crossref","first-page":"10646","DOI":"10.1073\/pnas.0504927102","article-title":"Activation of \u03b2-catenin by carcinogenic Helicobacter pylori","volume":"102","author":"Franco","year":"2005","journal-title":"Proc. Natl. Acad. Sci. u S. a"},{"issue":"10","key":"10.1016\/j.ctarc.2026.101363_bib0037","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1158\/0008-5472.CAN-19-3074","article-title":"Blockade of \u03b2-catenin-induced CCL28 suppresses gastric cancer progression via inhibition of treg cell infiltration","volume":"80","author":"Ji","year":"2020","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101363_bib0038","doi-asserted-by":"crossref","first-page":"84","DOI":"10.5493\/wjem.v5.i2.84","article-title":"Role of the wnt\/β-catenin pathway in gastric cancer: an in-depth literature review","volume":"5","author":"Chiurillo","year":"2015","journal-title":"World J. Exp. Med."},{"issue":"7","key":"10.1016\/j.ctarc.2026.101363_bib0039","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.2174\/011574888X259932231010112521","article-title":"RHBDD1 Promotes the growth and stemness characteristics of gastric cancer cells by activating wnt\/\u03b2-catenin signaling pathway","volume":"19","author":"Yang","year":"2024","journal-title":"Curr. Stem Cell Res. Ther."},{"issue":"11","key":"10.1016\/j.ctarc.2026.101363_bib0040","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.3390\/ijms21113927","article-title":"Targeting wnt signaling for the treatment of gastric cancer","volume":"21","author":"Koushyar","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"16","key":"10.1016\/j.ctarc.2026.101363_bib0041","doi-asserted-by":"crossref","first-page":"5901","DOI":"10.3390\/ijms21165901","article-title":"2,4-Diamino-quinazoline, a wnt signaling inhibitor, suppresses gastric cancer progression and metastasis","volume":"21","author":"Chang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101363_bib0042","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.celrep.2016.05.071","article-title":"Direct targeting of \u03b2-catenin by a small molecule stimulates proteasomal degradation and suppresses oncogenic wnt\/\u03b2-catenin signaling","volume":"16","author":"Hwang","year":"2016","journal-title":"Cell Rep."},{"issue":"28","key":"10.1016\/j.ctarc.2026.101363_bib0043","doi-asserted-by":"crossref","first-page":"e220","DOI":"10.3346\/jkms.2022.37.e220","article-title":"Establishment of patient-derived gastric cancer organoid model from tissue obtained by endoscopic biopsies","volume":"37","author":"Song","year":"2022","journal-title":"J. Korean Med. Sci."},{"issue":"11","key":"10.1016\/j.ctarc.2026.101363_bib0044","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202402783","article-title":"Helicobacter pylori induces the expression of Lgr5 and stem cell properties in gastric target cells","volume":"7","author":"Nascakova","year":"2024","journal-title":"Life Sci. Alliance"},{"issue":"8","key":"10.1016\/j.ctarc.2026.101363_bib0045","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/s43018-023-00609-9","article-title":"WNTinib is a multi-kinase inhibitor with specificity against \u03b2-catenin mutant hepatocellular carcinoma","volume":"4","author":"Rialdi","year":"2023","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.ctarc.2026.101363_bib0046","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41420-021-00803-7","article-title":"Establishment of gastric signet ring cell carcinoma organoid for the therapeutic drug testing","volume":"8","author":"Li","year":"2022","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.ctarc.2026.101363_bib0047","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2025.1631168","article-title":"Patient-derived gastric cancer organoids model heterogeneity and stroma-mediated chemoresistance in poorly cohesive carcinoma","volume":"12","author":"Yin","year":"2025","journal-title":"Front. Mol. Biosci."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101363_bib0048","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00428-014-1588-4","article-title":"The PI3K\/AKT\/mTOR pathway is activated in gastric cancer with potential prognostic and predictive significance","volume":"465","author":"Tapia","year":"2014","journal-title":"Virchows Arch."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101363_bib0049","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.3390\/cancers6031441","article-title":"The role of PI3K\/akt\/mTOR signaling in gastric carcinoma","volume":"6","author":"Matsuoka","year":"2014","journal-title":"Cancers (Basel)"},{"issue":"10","key":"10.1016\/j.ctarc.2026.101363_bib0050","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1007\/s10620-024-08649-6","article-title":"ACTL8 Promotes the progression of gastric cancer through PI3K\/AKT\/mTOR signaling pathway","volume":"69","author":"Yu","year":"2024","journal-title":"Dig. Dis. Sci."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101363_bib0052","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.3390\/ijms25031848","article-title":"Targeting PI3K\/AKT\/mTOR and MAPK signaling pathways in gastric cancer","volume":"25","author":"Morgos","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"43","key":"10.1016\/j.ctarc.2026.101363_bib0053","doi-asserted-by":"crossref","DOI":"10.3748\/wjg.v21.i43.12261","article-title":"Targeting the PI3K\/Akt signaling pathway in gastric carcinoma: a reality for personalized medicine?","volume":"21","author":"Singh","year":"2015","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101363_bib0054","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3390\/biom11020150","article-title":"Efficacy of providing the PI3K p110\u03b1 inhibitor BYL719 (Alpelisib) to middle-aged mice in their diet","volume":"11","author":"Hedges","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.ctarc.2026.101363_bib0055","author":"Zhou"},{"issue":"19","key":"10.1016\/j.ctarc.2026.101363_bib0056","doi-asserted-by":"crossref","first-page":"5755","DOI":"10.1158\/1078-0432.CCR-06-0118","article-title":"A phase I and pharmacokinetic study of Temsirolimus (CCI-779) administered intravenously daily for 5 days every 2 weeks to patients with advanced cancer","volume":"12","author":"Hidalgo","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ctarc.2026.101363_bib0057","article-title":"Everolimus for previously treated advanced gastric cancer: results of the randomized, double-blind, phase III GRANITE-1 study","year":"2025","journal-title":"J. Clin. Oncol. [Internet]"},{"key":"10.1016\/j.ctarc.2026.101363_bib0058","article-title":"Phase IB study of the mTOR inhibitor Ridaforolimus with Capecitabine","year":"2025","journal-title":"J. Clin. Oncol. [Internet]"},{"key":"10.1016\/j.ctarc.2026.101363_bib0059","article-title":"PI3K\/Akt\/mTOR pathway and its role in cancer therapeutics: are we making headway?","volume":"12","author":"Peng","year":"2022","journal-title":"Front. Oncol."},{"issue":"7","key":"10.1016\/j.ctarc.2026.101363_bib0061","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.3390\/ijms22073464","article-title":"PI3K inhibitors in cancer: clinical implications and adverse effects","volume":"22","author":"Mishra","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"22","key":"10.1016\/j.ctarc.2026.101363_bib0062","doi-asserted-by":"crossref","first-page":"5792","DOI":"10.3390\/ijms20225792","article-title":"PI3K\/mTOR pathway inhibition: opportunities in oncology and rare genetic diseases","volume":"20","author":"Hillmann","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101363_bib0063","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12943-019-0954-x","article-title":"Targeting PI3K in cancer: mechanisms and advances in clinical trials","volume":"18","author":"Yang","year":"2019","journal-title":"Mol. Cancer"},{"issue":"Suppl 1","key":"10.1016\/j.ctarc.2026.101363_bib0064","doi-asserted-by":"crossref","first-page":"A41","DOI":"10.1186\/1471-2210-10-S1-A41","article-title":"BEZ235 impairs gastric cancer growth by inhibition of PI3K\/mTOR in vitro and in vivo","volume":"10","author":"F\u00fcreder","year":"2010","journal-title":"BMC Pharmacol."},{"key":"10.1016\/j.ctarc.2026.101363_bib0065","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.920444","article-title":"Patient derived organoids confirm that PI3K\/AKT signalling is an escape pathway for radioresistance and a target for therapy in rectal cancer","volume":"12","author":"Wanigasooriya","year":"2022","journal-title":"Front. Oncol."},{"issue":"32","key":"10.1016\/j.ctarc.2026.101363_bib0066","article-title":"Loss of ATOH1 in pit cell drives stemness and progression of gastric adenocarcinoma by activating AKT\/mTOR signaling through GAS1","volume":"10","author":"Zhong","year":"2023","journal-title":"Adv. Sci. (Weinh)"},{"issue":"9","key":"10.1016\/j.ctarc.2026.101363_bib0067","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41419-024-07077-8","article-title":"Targeted therapy of cancer stem cells: inhibition of mTOR in pre-clinical and clinical research","volume":"15","author":"Son","year":"2024","journal-title":"Cell Death. Dis."},{"key":"10.1016\/j.ctarc.2026.101363_bib0068","article-title":"ASF1B promotes gastric cancer progression by modulating H2AC20 and activating PI3K\/AKT and ERK1\/2 pathways","volume":"16","author":"Zhao","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"18","key":"10.1016\/j.ctarc.2026.101363_bib0069","doi-asserted-by":"crossref","first-page":"7007","DOI":"10.7150\/thno.98389","article-title":"BATF2 inhibits the stem cell-like properties and chemoresistance of gastric cancer cells through PTEN\/AKT\/\u03b2-catenin pathway","volume":"14","author":"Cao","year":"2024","journal-title":"Theranostics"},{"issue":"8","key":"10.1016\/j.ctarc.2026.101363_bib0070","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.3390\/ijms21082893","article-title":"MAP kinases pathways in gastric cancer","volume":"21","author":"Magnelli","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101363_bib0071","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/cas.12901","article-title":"Inflammation in gastric cancer: interplay of the COX-2\/prostaglandin E2 and toll-like receptor\/MyD88 pathways","volume":"107","author":"Echizen","year":"2016","journal-title":"Cancer Sci."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101363_bib0072","doi-asserted-by":"crossref","first-page":"257","DOI":"10.4236\/jct.2023.146022","article-title":"Exploration of Kras mutations and their potential for being a target molecule in cancer chemotherapy","volume":"14","author":"Chinthareddy","year":"2023","journal-title":"J. Cancer Ther."},{"key":"10.1016\/j.ctarc.2026.101363_bib0073","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1187638","article-title":"Helicobacter pylori regulates stomach diseases by activating cell pathways and DNA methylation of host cells","volume":"11","author":"Xi","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101363_bib0075","first-page":"1","article-title":"Exploring the mechanism of Weikang Keli in inhibiting gastric cancer through the MAPK signaling pathway: based on network pharmacology and experimental verification","volume":"2022","author":"Shao","year":"2022","journal-title":"Evid.-Based Compl. Altern. Medicine"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101363_bib0076","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s13277-015-4408-9","article-title":"Monoclonal antibodies-based treatment in gastric cancer: current status and future perspectives","volume":"37","author":"Roviello","year":"2016","journal-title":"Tumor Biol."},{"key":"10.1016\/j.ctarc.2026.101363_bib0077","author":"Smyth"},{"issue":"2","key":"10.1016\/j.ctarc.2026.101363_bib0078","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1136\/gutjnl-2017-314549","article-title":"Human gastric cancer modelling using organoids","volume":"68","author":"Seidlitz","year":"2019","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.ctarc.2026.101363_bib0079","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202215705","article-title":"Sensitivity towards HDAC inhibition is associated with RTK\/MAPK pathway activation in gastric cancer","volume":"14","author":"Seidlitz","year":"2022","journal-title":"EMBo Mol. Med."},{"key":"10.1016\/j.ctarc.2026.101363_bib0080","doi-asserted-by":"crossref","first-page":"64","DOI":"10.21037\/tgh.2017.07.02","article-title":"Management of gastric cancer in Indian population","volume":"2","author":"Ibrahim","year":"2017","journal-title":"Transl. Gastroenterol. Hepatol."},{"issue":"12","key":"10.1016\/j.ctarc.2026.101363_bib0081","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.3390\/cancers15123248","article-title":"Targeted therapies and developing precision medicine in gastric cancer","volume":"15","author":"Pihlak","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101363_bib0082","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13045-023-01451-3","article-title":"Gastric cancer treatment: recent progress and future perspectives","volume":"16","author":"Guan","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.ctarc.2026.101363_bib0083","unstructured":"The hedgehog signaling network and the development of gastric cancer | IntechOpen [Internet]. [cited 2025 Nov 5]. Available from: https:\/\/www.intechopen.com\/chapters\/17337."},{"issue":"22","key":"10.1016\/j.ctarc.2026.101363_bib0084","doi-asserted-by":"crossref","first-page":"7061","DOI":"10.1158\/0008-5472.CAN-11-1338","article-title":"Sonic hedgehog pathway promotes metastasis and lymphangiogenesis via activation of akt, EMT, and MMP-9 pathway in gastric cancer","volume":"71","author":"Yoo","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.ctarc.2026.101363_bib0085","doi-asserted-by":"crossref","unstructured":"S.C. Oh Data from Sonic Hedgehog pathway promotes metastasis and lymphangiogenesis via activation of Akt, EMT, and MMP-9 pathway in gastric cancer [Internet]. 2023 Mar 30. doi:10.1158\/0008-5472.c.6503139.v1.","DOI":"10.1158\/0008-5472.c.6503139.v1"},{"issue":"5","key":"10.1016\/j.ctarc.2026.101363_bib0086","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.3892\/ol.2015.2988","article-title":"Resveratrol inhibits the hedgehog signaling pathway and epithelial-mesenchymal transition and suppresses gastric cancer invasion and metastasis","volume":"9","author":"Gao","year":"2015","journal-title":"Oncol. Lett."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101363_bib0087","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/sj.bjc.6604846","article-title":"Cross talk between hedgehog and epithelial\u2013mesenchymal transition pathways in gastric pit cells and in diffuse-type gastric cancers","volume":"100","author":"Ohta","year":"2009","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ctarc.2026.101363_bib0088","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114647","article-title":"Sterol regulation of developmental and oncogenic hedgehog signaling","volume":"196","author":"Daggubati","year":"2022","journal-title":"Biochem. Pharmacol."},{"issue":"Suppl 2","key":"10.1016\/j.ctarc.2026.101363_bib0089","doi-asserted-by":"crossref","first-page":"S267","DOI":"10.4103\/jcrt.jcrt_739_21","article-title":"Role of sonic hedgehog ligand in gastric cancer therapeutics","volume":"18","author":"Akhtar","year":"2022","journal-title":"J. Cancer Res. Ther."},{"key":"10.1016\/j.ctarc.2026.101363_bib0090","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.12659\/MSM.903012","article-title":"Targeting smoothened sensitizes gastric cancer to chemotherapy in experimental models","volume":"23","author":"Ma","year":"2017","journal-title":"Med. Sci. Monit."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101363_bib0091","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1089\/biores.2014.0001","article-title":"Sonic hedgehog pathway contributes to gastric cancer cell growth and proliferation","volume":"3","author":"Wan","year":"2014","journal-title":"Biores. Open Access."},{"issue":"100","key":"10.1016\/j.ctarc.2026.101363_bib0092","doi-asserted-by":"crossref","first-page":"37439","DOI":"10.18632\/oncotarget.26473","article-title":"Hedgehog signaling induces PD-L1 expression and tumor cell proliferation in gastric cancer","volume":"9","author":"Chakrabarti","year":"2018","journal-title":"Oncotarget."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101363_bib0093","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007468","article-title":"Increased programmed death-Ligand 1 is an early epithelial cell response to Helicobacter pylori infection","volume":"15","author":"Holokai","year":"2019","journal-title":"PLoS. Pathog."},{"key":"10.1016\/j.ctarc.2026.101363_bib0094","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.canlet.2021.06.007","article-title":"Hedgehog transcriptional effector GLI mediates mTOR-induced PD-L1 expression in gastric cancer organoids","volume":"518","author":"Koh","year":"2021","journal-title":"Cancer Lett."},{"issue":"8","key":"10.1016\/j.ctarc.2026.101363_bib0095","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.3390\/cells9081879","article-title":"Cancer stem cells, quo Vadis? The notch signaling pathway in tumor initiation and progression","volume":"9","author":"Meisel","year":"2020","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101363_bib0097","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41392-024-01828-x","article-title":"Notch signaling pathway in cancer: from mechanistic insights to targeted therapies","volume":"9","author":"Shi","year":"2024","journal-title":"Sig Transduct Target Ther"},{"issue":"12","key":"10.1016\/j.ctarc.2026.101363_bib0099","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1080\/10286020.2023.2202854","article-title":"Flavonoids as emerging notch signaling pathway modulators in cancer","volume":"25","author":"Singh","year":"2023","journal-title":"J. Asian Nat. Prod. Res."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101363_bib0100","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.bbcan.2010.06.001","article-title":"Targeting notch signaling pathway to overcome drug resistance for cancer therapy","volume":"1806","year":"2010","journal-title":"Biochimica et Biophysica Acta (BBA) - Rev.Cancer"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101363_bib0101","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13045-023-01439-z","article-title":"The notch signaling pathway: a potential target for cancer immunotherapy","volume":"16","author":"Li","year":"2023","journal-title":"J. Hematol. Oncol."},{"issue":"7","key":"10.1016\/j.ctarc.2026.101363_bib0102","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.neo.2019.05.002","article-title":"Notch and mTOR signaling pathways promote Human gastric cancer cell proliferation","volume":"21","author":"Hibdon","year":"2019","journal-title":"Neoplasia"},{"key":"10.1016\/j.ctarc.2026.101363_bib0103","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217886","article-title":"CD51 promotes gastric cancer stemness via blocking numb-mediated Notch1 degradation","volume":"629","author":"Peng","year":"2025","journal-title":"Cancer Lett."},{"issue":"20","key":"10.1016\/j.ctarc.2026.101363_bib0104","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.15252\/embj.201490583","article-title":"Notch signaling regulates gastric antral LGR5 stem cell function","volume":"34","author":"Demitrack","year":"2015","journal-title":"EMBO J."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101363_bib0105","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41575-019-0255-2","article-title":"Organoid models of gastrointestinal cancers in basic and translational research","volume":"17","author":"Lau","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"10","key":"10.1016\/j.ctarc.2026.101363_bib0106","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.3390\/cancers12102800","article-title":"Le Jossic-Corcos C. Three-dimensional culture systems in gastric cancer research","volume":"12","author":"Alzeeb","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.ctarc.2026.101363_bib0107","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1136\/gutjnl-2014-307650","article-title":"Helicobacter pylori targets cancer-associated apical-junctional constituents in gastroids and gastric epithelial cells","volume":"64","author":"Wroblewski","year":"2015","journal-title":"Gut"},{"issue":"5391","key":"10.1016\/j.ctarc.2026.101363_bib0108","first-page":"1145","article-title":"Embryonic stem cell lines derived from human blastocysts","volume":"282","author":"Thomson","year":"1998","journal-title":"Science (1979)"},{"issue":"4","key":"10.1016\/j.ctarc.2026.101363_bib0109","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101363_bib0110","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.stem.2009.11.013","article-title":"Lgr5(+ve) stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro","volume":"6","author":"Barker","year":"2010","journal-title":"Cell Stem Cell"},{"issue":"7244","key":"10.1016\/j.ctarc.2026.101363_bib0111","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nature07935","article-title":"Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche","volume":"459","author":"Sato","year":"2009","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101363_bib0112","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1053\/j.gastro.2014.09.042","article-title":"In vitro expansion of human gastric epithelial stem cells and their responses to bacterial infection","volume":"148","author":"Bartfeld","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ctarc.2026.101363_bib0113","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2025.1572244","article-title":"Application of an organoid-based model to explore Helicobacter pylori-human gastric epithelium interaction in vitro","volume":"15","author":"Yu","year":"2025","journal-title":"Front. Cell Infect. Microbiol."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101363_bib0114","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1136\/gutjnl-2017-314540","article-title":"Polarised epithelial monolayers of the gastric mucosa reveal insights into mucosal homeostasis and defence against infection","volume":"68","author":"Boccellato","year":"2019","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101363_bib0115","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1038\/s41467-025-57131-y","article-title":"Accessible homeostatic gastric organoids reveal secondary cell type-specific host-pathogen interactions in Helicobacter pylori infections","volume":"16","author":"Hofer","year":"2025","journal-title":"Nat. Commun."},{"issue":"7531","key":"10.1016\/j.ctarc.2026.101363_bib0116","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nature13863","article-title":"Modeling human development and disease in pluripotent stem cell-derived gastric organoids","volume":"516","author":"McCracken","year":"2014","journal-title":"Nature"},{"issue":"7636","key":"10.1016\/j.ctarc.2026.101363_bib0117","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nature21021","article-title":"Wnt\/\u03b2-catenin promotes gastric fundus specification in mice and humans","volume":"541","author":"McCracken","year":"2017","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.ctarc.2026.101363_bib0118","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.stem.2018.09.016","article-title":"A comprehensive Human gastric cancer organoid biobank captures tumor subtype heterogeneity and enables therapeutic screening","volume":"23","author":"Yan","year":"2018","journal-title":"Cell Stem Cell"},{"issue":"7","key":"10.1016\/j.ctarc.2026.101363_bib0119","article-title":"Personalized drug screening using patient-derived organoid and its clinical relevance in gastric cancer","volume":"5","author":"Zhao","year":"2024","journal-title":"Cell Rep. Med."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101363_bib0120","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1053\/j.gastro.2008.10.011","article-title":"Helicobacter pylori dysregulation of gastric epithelial tight junctions by urease-mediated myosin II activation","volume":"136","author":"Wroblewski","year":"2009","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101363_bib0122","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41420-025-02505-w","article-title":"Breakthroughs and challenges of organoid models for assessing cancer immunotherapy: a cutting-edge tool for advancing personalised treatments","volume":"11","author":"Wang","year":"2025","journal-title":"Cell Death. Discov."},{"key":"10.1016\/j.ctarc.2026.101363_bib0123","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217122","article-title":"Establishment of advanced tumor organoids with emerging innovative technologies","volume":"598","author":"Mao","year":"2024","journal-title":"Cancer Lett."},{"issue":"7","key":"10.1016\/j.ctarc.2026.101363_bib0125","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1038\/s12276-024-01272-5","article-title":"Patient-derived tumor organoids: a new avenue for preclinical research and precision medicine in oncology","volume":"56","author":"Thorel","year":"2024","journal-title":"Exp. Mol. Med."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101363_bib0126","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jcmgh.2018.09.008","article-title":"An organoid-based preclinical model of Human gastric cancer","volume":"7","author":"Steele","year":"2019","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"issue":"12","key":"10.1016\/j.ctarc.2026.101363_bib0127","article-title":"Comparison of gastric cancer models using different dimensions In vitro","volume":"8","author":"Zheng","year":"2025","journal-title":"Cancer Rep."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101363_bib0128","first-page":"964","article-title":"A gastric cancer patient-derived three-dimensional cell spheroid culture model","volume":"13","author":"Zhang","year":"2023","journal-title":"Am. J. Cancer Res."},{"issue":"8","key":"10.1016\/j.ctarc.2026.101363_bib0129","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1111\/cas.15840","article-title":"Novel and efficient method for culturing patient-derived gastric cancer stem cells","volume":"114","author":"Morimoto","year":"2023","journal-title":"Cancer Sci."},{"key":"10.1016\/j.ctarc.2026.101363_bib0130","series-title":"Current Limitations of Organoid Technology","year":"2023"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101363_bib0131","doi-asserted-by":"crossref","first-page":"5878","DOI":"10.1038\/s41467-022-33165-4","article-title":"Helicobacter pylori shows tropism to gastric differentiated pit cells dependent on urea chemotaxis","volume":"13","author":"Aguilar","year":"2022","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.ctarc.2026.101363_bib0132","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1056\/NEJMoa001999","article-title":"Helicobacter pylori infection and the development of gastric cancer","volume":"345","author":"Uemura","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ctarc.2026.101363_bib0133","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.micpath.2018.06.033","article-title":"The role of T helper 1-cell response in Helicobacter pylori-infection","volume":"123","author":"Bagheri","year":"2018","journal-title":"Microb. Pathog."},{"issue":"6776","key":"10.1016\/j.ctarc.2026.101363_bib0134","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/35006081","article-title":"Interleukin-1 polymorphisms associated with increased risk of gastric cancer","volume":"404","author":"El-Omar","year":"2000","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.ctarc.2026.101363_bib0135","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1128\/IAI.01271-12","article-title":"High dietary salt intake exacerbates Helicobacter pylori-induced gastric carcinogenesis","volume":"81","author":"Gaddy","year":"2013","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101363_bib0136","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1172\/JCI64373","article-title":"Iron deficiency accelerates Helicobacter pylori\u2013induced carcinogenesis in rodents and humans","volume":"123","author":"Noto","year":"2013","journal-title":"J. Clin. Invest."},{"issue":"5349","key":"10.1016\/j.ctarc.2026.101363_bib0137","first-page":"373","article-title":"Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging","volume":"279","author":"Ilver","year":"1998","journal-title":"Science (1979)"},{"issue":"7","key":"10.1016\/j.ctarc.2026.101363_bib0138","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1053\/j.gastro.2015.02.049","article-title":"Helicobacter pylori activates and expands Lgr5+ stem cells through direct colonization of the gastric glands","volume":"148","author":"Sigal","year":"2015","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.ctarc.2026.101363_bib0139","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1128\/IAI.66.5.2346-2348.1998","article-title":"Proteins encoded by the cag pathogenicity Island of Helicobacter pylori are required for NF-\u03bab activation","volume":"66","author":"Glocker","year":"1998","journal-title":"Infect. Immun."},{"issue":"8964","key":"10.1016\/j.ctarc.2026.101363_bib0140","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/S0140-6736(95)91084-0","article-title":"Long-term sequelae of Helicobacter pylori gastritis","volume":"345","author":"Kuipers","year":"1995","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101363_bib0141","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1053\/j.gastro.2010.09.048","article-title":"Lack of commensal flora in H. pylori-infected INS-GAS mice reduces gastritis and delays intraepithelial neoplasia","volume":"140","author":"Lofgren","year":"2011","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.ctarc.2026.101363_bib0142","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1128\/IAI.01437-15","article-title":"Gastric metaplasia induced by Helicobacter pylori is associated with enhanced SOX9 expression via interleukin-1 signaling","volume":"84","author":"Serizawa","year":"2016","journal-title":"Infect. Immun."},{"issue":"7","key":"10.1016\/j.ctarc.2026.101363_bib0143","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1136\/gutjnl-2016-311685","article-title":"Dynamics of Helicobacter pylori infection as a determinant of progression of gastric precancerous lesions: 16-year follow-up of an eradication trial","volume":"67","author":"Mera","year":"2018","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.ctarc.2026.101363_bib0144","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S0016-5085(98)70143-X","article-title":"Helicobacter pylori infection induces gastric cancer in Mongolian gerbils","volume":"115","author":"Watanabe","year":"1998","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.ctarc.2026.101363_bib0145","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1073\/pnas.0711183105","article-title":"Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse","volume":"105","author":"Ohnishi","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ctarc.2026.101363_bib0146","article-title":"Transcriptional profiling reveals H.pylori-associated genes induced inflammatory cell infiltration and chemoresistance in gastric cancer","volume":"16","author":"Tan","year":"2025","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101363_bib0149","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1080\/19490976.2020.1762520","article-title":"The role of gastric microbiota in gastric cancer","volume":"11","author":"Stewart","year":"2020","journal-title":"Gut Microbes"},{"issue":"4","key":"10.1016\/j.ctarc.2026.101363_bib0150","doi-asserted-by":"crossref","first-page":"196","DOI":"10.2183\/pjab.93.013","article-title":"Structure and function of Helicobacter pylori CagA, the first-identified bacterial protein involved in human cancer","volume":"93","author":"Hatakeyama","year":"2017","journal-title":"Proc. Jpn. Acad. Ser. B Phys. Biol. Sci."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101363_bib0151","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/nrmicro1095","article-title":"Helicobacter pylori VacA, a paradigm for toxin multifunctionality","volume":"3","author":"Cover","year":"2005","journal-title":"Nat. Rev. Microbiol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101363_bib0152","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01869-15","article-title":"Helicobacter pylori diversity and gastric cancer risk","volume":"7","author":"Cover","year":"2016","journal-title":"mBio"},{"issue":"6","key":"10.1016\/j.ctarc.2026.101363_bib0153","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1128\/iai.62.6.2609-2613.1994","article-title":"Mutation of the cytotoxin-associated cagA gene does not affect the vacuolating cytotoxin activity of Helicobacter pylori","volume":"62","author":"Tummuru","year":"1994","journal-title":"Infect. Immun."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101363_bib0154","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1136\/gut.2005.083014","article-title":"Helicobacter pylori outer membrane proteins and gastroduodenal disease","volume":"55","author":"Yamaoka","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.ctarc.2026.101363_bib0155","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.765842","article-title":"Curcumin oxidation is required for inhibition of Helicobacter pylori growth, translocation and phosphorylation of cag A","volume":"11","author":"Ray","year":"2021","journal-title":"Front. Cell Infect. Microbiol."},{"issue":"24","key":"10.1016\/j.ctarc.2026.101363_bib0156","doi-asserted-by":"crossref","first-page":"6158","DOI":"10.3390\/cancers13246158","article-title":"Disruption of Her2-induced PD-L1 inhibits tumor cell immune evasion in patient-derived gastric cancer organoids","volume":"13","author":"Chakrabarti","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101363_bib0157","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41392-023-01559-5","article-title":"Hedgehog signaling in tissue homeostasis, cancers and targeted therapies","volume":"8","author":"Jing","year":"2023","journal-title":"Sign. Transduct. Target Ther."},{"key":"10.1016\/j.ctarc.2026.101363_bib0158","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41420-025-02327-w","article-title":"Mechanisms and therapeutic potential of the hedgehog signaling pathway in cancer","volume":"11","author":"Cong","year":"2025","journal-title":"Cell Death Discov."},{"issue":"11","key":"10.1016\/j.ctarc.2026.101363_bib0159","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111693","article-title":"High-throughput sequencing and copy number variation detection using Formalin fixed embedded tissue in metastatic gastric cancer","volume":"9","author":"Kim","year":"2014","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.ctarc.2026.101363_bib0160","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.3390\/cancers12071981","article-title":"High-throughput sequencing of gastric cancer patients: unravelling genetic predispositions towards an early-onset subtype","volume":"12","author":"Machlowska","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.ctarc.2026.101363_bib0161","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagen.2024.130566","article-title":"Gastric cancer patient-derived organoids model for the therapeutic drug screening","volume":"1868","author":"Xu","year":"2024","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.ctarc.2026.101363_bib0162","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114751","article-title":"Patient-derived organoid culture of gastric cancer for disease modeling and drug sensitivity testing","volume":"163","author":"Zu","year":"2023","journal-title":"Biomed. PharmacOther."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101363_bib0163","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1158\/2159-8290.CD-20-1109","article-title":"A CRISPR\/Cas9-engineered ARID1A-deficient Human gastric cancer organoid model reveals essential and nonessential modes of oncogenic transformation","volume":"11","author":"Lo","year":"2021","journal-title":"Cancer Discov."},{"issue":"28","key":"10.1016\/j.ctarc.2026.101363_bib0164","doi-asserted-by":"crossref","first-page":"24750","DOI":"10.18632\/oncotarget.4990","article-title":"Molecular classification of gastric cancer: towards a pathway-driven targeted therapy","volume":"6","author":"Riquelme","year":"2015","journal-title":"Oncotarget."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101363_bib0165","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1634\/theoncologist.2011-0311","article-title":"Targeted therapy in the management of advanced gastric cancer: are we making progress in the era of personalized medicine?","volume":"17","author":"Wong","year":"2012","journal-title":"Oncologist."},{"issue":"11","key":"10.1016\/j.ctarc.2026.101363_bib0166","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.3390\/cancers15113036","article-title":"Creation of EGD-derived gastric cancer organoids to predict treatment responses","volume":"15","author":"McDonald","year":"2023","journal-title":"Cancers. (Basel)"},{"key":"10.1016\/j.ctarc.2026.101363_bib0167","series-title":"Hereditary Gastric and Breast Cancer Syndrome: CDH1: One Genotype With Multiple Phenotypes [Internet]","first-page":"281","article-title":"Drug repurposing in gastric cancer: current status and Future perspectives","author":"Leite","year":"2023"},{"issue":"39","key":"10.1016\/j.ctarc.2026.101363_bib0168","doi-asserted-by":"crossref","DOI":"10.3748\/wjg.v31.i39.110986","article-title":"Targetable pathways for drug repurposing in gastric cancer","volume":"31","author":"Valero-Almingol","year":"2025","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ctarc.2026.101363_bib0169","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.102054","article-title":"Cinobufacini enhances the therapeutic response of 5-Fluorouracil against gastric cancer by targeting cancer stem cells via AKT\/GSK-3\u03b2\/\u03b2-catenin signaling axis","volume":"47","author":"Sun","year":"2024","journal-title":"Transl. Oncol."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101363_bib0170","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.3748\/wjg.v22.i3.1160","article-title":"Personalized medicine in gastric cancer: where are we and where are we going?","volume":"22","author":"J\u00e1come","year":"2016","journal-title":"World J. Gastroenterol."},{"issue":"17","key":"10.1016\/j.ctarc.2026.101363_bib0171","doi-asserted-by":"crossref","first-page":"4425","DOI":"10.1158\/1078-0432.CCR-13-0753","article-title":"New strategies in personalized medicine for solid tumors: molecular markers and clinical trial designs","volume":"20","author":"J\u00fcrgensmeier","year":"2014","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101363_bib0172","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s44164-025-00086-7","article-title":"Organoids meet microfluidics: recent advancements, challenges, and future of organoids-on-chip","volume":"4","author":"Chauhdari","year":"2025","journal-title":"In Vitro Models"},{"key":"10.1016\/j.ctarc.2026.101363_bib0173","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1432744","article-title":"Technological advances and challenges in constructing complex gut organoid systems","volume":"12","author":"Zheng","year":"2024","journal-title":"Front. Cell Dev. Biol."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101363_bib0174","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1053\/j.gastro.2020.10.047","article-title":"Wnt signaling shapes the histologic variation in diffuse gastric cancer","volume":"160","author":"Togasaki","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ctarc.2026.101363_bib0175","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1146\/annurev-neuro-111020-090812","article-title":"Challenges of organoid research","volume":"45","author":"Andrews","year":"2022","journal-title":"Annu Rev. Neurosci."},{"issue":"7","key":"10.1016\/j.ctarc.2026.101363_bib0176","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1007\/s00432-022-04296-4","article-title":"Clinical value and influencing factors of establishing stomach cancer organoids by endoscopic biopsy","volume":"149","author":"Li","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101363_bib0177","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.molmed.2017.02.007","article-title":"Disease modeling in stem cell-derived 3D organoid systems","volume":"23","author":"Dutta","year":"2017","journal-title":"Trends. Mol. Med."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101363_bib0178","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/ncb3312","article-title":"Organoids as an in vitro model of human development and disease","volume":"18","author":"Fatehullah","year":"2016","journal-title":"Nat. Cell Biol."},{"issue":"10","key":"10.1016\/j.ctarc.2026.101363_bib0179","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/s41580-020-0259-3","article-title":"Human organoids: model systems for human biology and medicine","volume":"21","author":"Kim","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"9","key":"10.1016\/j.ctarc.2026.101363_bib0180","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.chembiol.2017.06.012","article-title":"Tumor organoids as a pre-clinical cancer model for drug discovery","volume":"24","author":"Weeber","year":"2017","journal-title":"Cell Chem. Biol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101363_bib0181","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41418-020-00662-2","article-title":"Gastric organoids-an in vitro model system for the study of gastric development and road to personalized medicine","volume":"28","author":"Seidlitz","year":"2021","journal-title":"Cell Death Differ."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101363_bib0182","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12891","article-title":"Gastric organoids: advancing the study of H. pylori pathogenesis and inflammation","volume":"27","author":"Idowu","year":"2022","journal-title":"Helicobacter."},{"key":"10.1016\/j.ctarc.2026.101363_bib0183","doi-asserted-by":"crossref","DOI":"10.1016\/j.crtox.2024.100197","article-title":"iPSC-derived and patient-derived organoids: applications and challenges in scalability and reproducibility as pre-clinical models","volume":"7","author":"Heinzelmann","year":"2024","journal-title":"Curr. Res. Toxicol."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101363_bib0184","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/biotech10030012","article-title":"Ethical challenges in organoid use","volume":"10","author":"Mollaki","year":"2021","journal-title":"BioTech. (Basel)"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101363_bib0185","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1186\/s13287-022-02950-9","article-title":"Organoids: a systematic review of ethical issues","volume":"13","author":"de Jongh","year":"2022","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.ctarc.2026.101363_bib0187","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1074268","article-title":"Single-cell transcriptome sequencing reveals heterogeneity of gastric cancer: progress and prospects","volume":"13","author":"Deng","year":"2023","journal-title":"Front. Oncol."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101363_bib0188","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.3390\/cancers14051252","article-title":"Functional ex vivo tissue-based chemotherapy sensitivity testing for breast cancer","volume":"14","author":"Ladan","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.ctarc.2026.101363_bib0189","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3390\/antib11020026","article-title":"Precision-cut tumor slices (PCTS) as an ex vivo model in immunotherapy research","volume":"11","author":"Dimou","year":"2022","journal-title":"Antibodies (Basel)"},{"issue":"4","key":"10.1016\/j.ctarc.2026.101363_bib0190","doi-asserted-by":"crossref","first-page":"114","DOI":"10.21037\/atm.2019.12.88","article-title":"Tumor slice culture as a biologic surrogate of human cancer","volume":"8","author":"Kenerson","year":"2020","journal-title":"Ann. Transl. Med."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101363_bib0191","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1007\/s13402-024-00935-9","article-title":"3D bioprinted tumor model: a prompt and convenient platform for overcoming immunotherapy resistance by recapitulating the tumor microenvironment","volume":"47","author":"Zhang","year":"2024","journal-title":"Cell Oncol. (Dordr)"},{"key":"10.1016\/j.ctarc.2026.101363_bib0192","article-title":"3D Bioprinting of tumor models for cancer research","year":"2025","journal-title":"ACS Appl. Bio Mater. [Internet]"},{"issue":"10","key":"10.1016\/j.ctarc.2026.101363_bib0193","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e20475","article-title":"Application of three-dimensional (3D) bioprinting in anti-cancer therapy","volume":"9","author":"Wu","year":"2023","journal-title":"Heliyon"},{"issue":"10","key":"10.1016\/j.ctarc.2026.101363_bib0194","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1039\/D2BM02060B","article-title":"3D bioprinting complex models of cancer","volume":"11","author":"Sharma","year":"2023","journal-title":"Biomater. Sci."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101363_bib0195","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12967-022-03405-8","article-title":"Patient-derived xenograft (PDX) models, applications and challenges in cancer research","volume":"20","author":"Abdolahi","year":"2022","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ctarc.2026.101363_bib0196","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.985154","article-title":"Patient-derived xenograft models for gastrointestinal tumors: a single-center retrospective study","volume":"12","author":"Yu","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ctarc.2026.101363_bib0197","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120957","article-title":"A novel organ-chip system emulates three-dimensional architecture of the human epithelia and the mechanical forces acting on it","volume":"275","author":"Varone","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.ctarc.2026.101363_bib0198","doi-asserted-by":"crossref","DOI":"10.1016\/j.bprint.2022.e00224","article-title":"The integration of spheroids and organoids into organ-on-a-chip platforms for tumour research: a review","volume":"27","author":"Carvalho","year":"2022","journal-title":"Bioprinting."},{"issue":"6444","key":"10.1016\/j.ctarc.2026.101363_bib0199","first-page":"960","article-title":"Organoids-on-a-chip","volume":"364","author":"Park","year":"2019","journal-title":"Science (1979)"},{"issue":"5","key":"10.1016\/j.ctarc.2026.101363_bib0200","doi-asserted-by":"crossref","first-page":"875","DOI":"10.3390\/biom13050875","article-title":"Organoids: construction and application in gastric cancer","volume":"13","author":"Huo","year":"2023","journal-title":"Biomolecules"},{"issue":"6","key":"10.1016\/j.ctarc.2026.101363_bib0201","doi-asserted-by":"crossref","first-page":"929","DOI":"10.3390\/jpm12060929","article-title":"Stem cell biomarkers and tumorigenesis in gastric cancer","volume":"12","author":"Wuputra","year":"2022","journal-title":"J. Pers. Med."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101363_bib0202","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s40164-023-00433-y","article-title":"The role of organoids in cancer research","volume":"12","author":"Fang","year":"2023","journal-title":"Exp. Hematol. Oncol."}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226002741?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226002741?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:53:09Z","timestamp":1790913189000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294226002741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":191,"alternative-id":["S2468294226002741"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101363","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of non-animal 3D models in H. pylori associated gastric carcinogenesis: Insights and future perspectives","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101363","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101363"}}